These results suggest that combined pharmacological inhibition of TNF and IL-6 in the context of severe HDM-induced asthma may provide benefit in TGF-β-dependent lung remodeling, as compared to inhibition of these cytokines individually. Here, TGFB1 is linked to asthma.